AstraZeneca estimates 2021 growth after beating 4th quarter sales, sees faster growth

11.02.2021 - Kulakov Vladimir
AstraZeneca estimates 2021 growth after beating 4th quarter sales, sees faster growth

Following a stronger-than-expected 4th quarter sales performance, COVID-19 vaccine developer AstraZeneca released its sales growth forecast for 2021 on Thursday. The British drug producer expects a “faster growth” in its core earnings.

AstraZeneca, a London-listed company, projected a $4.75 to $5.00 per share growth in its 2021 shares. Its low teens percentage forecasts came after hitting a $7.01 billion worth of product sales in the fourth quarter of 2020, beating its company-compiled consensus of $6.81 billion.

Last year, AstraZeneca worked with the University of Oxford to develop a COVID-19 vaccine. The vaccine developer’s biggest move in 2020 was when it made its largest deal, acquiring U>S.-based drug producer Alexion for $39 billion.

Despite “faster growth’ forecast, AstraZeneca said it did not consider the impact of its COVID-19 vaccine development.

Risk disclaimer "PROMETHEUS LTD – Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Republic of the Marshall Islands MH96960 is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0155 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of PROMETHEUS LTD and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from or PROMETHEUS LTD." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue

Help with deposit?